
Dr. Dana R. Sands is a Colorectal surgeon at Cleveland Clinic Florida Weston and she has over 25 years of experience in the medical field. Certified by the American Board of Colon and Rectal Surgery, her specialty interests include benign anorectal diseases, colorectal cancer, and transanal endoscopic microsurgery.
Selected publications from PubMed
Long-term Results of the North American Phase II Transanal Total Mesorectal Excision Multicenter Trial for Rectal Cancer.
Donovan KF, Carmichael H, Chadi S, Ricardo A, Bonaccorso A, Tomada EP, Sands D, Marks J, Maykel J, Alavi K, Zaghiyan K, Whiteford M, McLemore EC, Shawki SF, Steele S, Pigazzi A, Albert M, DeBeche-Adams T, Avery L, Wexner S, Sylla P
Ann Surg. 2026 Aug 1;284(2):236-243 doi: 10.1097/SLA.0000000000007044.
Impact of Obesity on Postoperative Outcomes in Transanal Total Mesorectal Excision for Rectal Cancer.
Zewde MG, Peyser DK, Yu AT, Bonaccorso AM, Moshier EL, Alavi K, Goldstone RN, Marks JH, Maykel JA, McLemore EC, Sands DR, Steele SR, Wexner SD, Whiteford MH, Sylla P
Dis Colon Rectum. 2026 Apr 1;69(4):553-564 doi: 10.1097/DCR.0000000000004090.
Impact of neoadjuvant treatment on functional outcomes after transanal total mesorectal excision (taTME)-a case series.
Donovan KF, Tomada EP, Carmichael H, Ricardo A, Berger N, Bonaccorso A, Alavi K, Zaghiyan K, Pigazzi A, Sands D, DeBeche-Adams T, Chadi SA, McLemore EC, Marks JH, Maykel JA, Shawki SF, Steele SR, Albert M, Whiteford MH, Wexner SD, Sylla P
Surg Endosc. 2025 Oct;39(10):6802-6812 doi: 10.1007/s00464-025-11959-z.
Functional Outcomes After Transanal Total Mesorectal Excision (taTME) for Rectal Cancer: Results From the Phase II North American Multicenter Prospective Observational Trial.
Donovan KF, Lee KC, Ricardo A, Berger N, Bonaccorso A, Alavi K, Zaghiyan K, Pigazzi A, Sands D, DeBeche-Adams T, Chadi SA, McLemore EC, Marks JH, Maykel JA, Shawki SF, Steele SR, Albert M, Whiteford MH, Cheng FY, Wexner SD, Sylla P
Ann Surg. 2024 Sep 1;280(3):363-373 doi: 10.1097/SLA.0000000000006374.
Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results.
Sylla P, Sands D, Ricardo A, Bonaccorso A, Polydorides A, Berho M, Marks J, Maykel J, Alavi K, Zaghiyan K, Whiteford M, Mclemore E, Chadi S, Shawki SF, Steele S, Pigazzi A, Albert M, DeBeche-Adams T, Moshier E, Wexner SD
Surg Endosc. 2023 Dec;37(12):9483-9508 doi: 10.1007/s00464-023-10266-9.
Help your network discover Dr. Dana Sands's clinical expertise.